| 标题 |
REZILIENT3: randomized phase III study of first-line zipalertinib plus chemotherapy in patients with EGFR exon 20 insertion-mutated NSCLC |
| 网址 | |
| DOI | |
| 其它 |
期刊:Future Oncology 作者:John V. Heymach; Helena A. Yu; Benjamin Besse; Ying Cheng; Daniel S.W. Tan; et al 出版日期:2025-02-16 |
| 求助人 | |
| 下载 |
PDF的下载单位、IP信息已删除
(2025-6-4)